Fed. Circ. Nixes Dr. Reddy's Patent Win On Generic Lunesta
The ruling completely flips a district court judge's January decision to grant Dr. Reddy's summary judgment of noninfringement. Rather than remanding for further proceedings, the Federal Circuit held that Dr. Reddy's abbreviated new drug application in fact infringes Sunovion's patent as a matter of law.
Sunovion's patent covers...
To view the full article, register now.